[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Orna Therapeutics, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100626758","phase-1-a-study-of-orn252-in-healthy-participants-100626758",false,"NCT07439796","A Study of ORN252 in Healthy Participants","A Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ORN252 in Healthy Participants","Inclusion Criteria:\n\n* Male and female participants who are healthy as determined by the Investigator based on review of medical history, physical examination, and laboratory tests\n* Participant is willing and able to comply with study visits and other protocol requirements\n* Other protocol specific inclusion criteria may apply\n\nExclusion Criteria:\n\n* Clinically significant history or presence of organ dysfunction\n* Use of any investigational product within 3 months, or 5 half-lives, whichever longer\n* Other protocol specific exclusion criteria may apply",true,"ALL","18 Years","55 Years",{"count":21,"type":22},20,"ESTIMATED","INTERVENTIONAL",[25],"PHASE1","The purpose of this study is to assess the safety and tolerability of ORN252 in healthy adult participants.",[28],"Healthy Volunteers - Male and Female","RECRUITING","2026-04-13",{"date":32,"type":33},"2026-04-16","ACTUAL",{"date":35,"type":33},"2026-03-16",{"date":37,"type":22},"2027-03",{"name":39,"class":40},"Orna Therapeutics, Inc.","INDUSTRY",""]